G

Gayassuddin

Active Director Director DIN 07400030
DIN 07400030 First appointment Jun 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2017
Shareholding value •••• Premium profile

About Gayassuddin

Data last updated:

Gayassuddin is a Director at Ayub And Sons Med Health Care Private Limited (since 2017). The company operates in Healthcare. Ayub And Sons Med Health Care Private Limited reported revenue of ₹77.2 Lakh (FY 2025).

DIN 07400030
Primary Designation Director
Industry Healthcare
First Appointment 22 Jun 2017
Oldest Company Age 9 yrs
Largest company Ayub And Sons Med Health Care Private Limited · ₹77.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jun 20172017₹77.2 Lakh (FY 2025)Active

Board colleagues of Gayassuddin

Directorship timeline

Open interactive timeline →
Ayub And Sons Med Health Care Private Limited
Premium access

Shareholding and investment profile for Gayassuddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gayassuddin

Gayassuddin currently holds 1 directorship: Ayub And Sons Med Health Care Private Limited (Director, since 22 Jun 2017, revenue ₹77.2 Lakh (FY 2025)).

Gayassuddin was first appointed on 22 Jun 2017 as Director at Ayub And Sons Med Health Care Private Limited.

The current boards of Gayassuddin's companies include Kamaluddin Mohd Choudhary (Ayub And Sons Med Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available